• tFUS Modulates Nespas/miR-383-3p/SHP2 Axis to Reduce Post-St

  2026-05-23

  This study demonstrates that transcranial focused ultrasound stimulation (tFUS) alleviates neuroinflammation after ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 pathway, leading to suppression of the NLRP3 inflammasome in microglia. These findings clarify the molecular underpinnings of tFUS neuroprotection and suggest new molecular targets for experimental stroke therapeutics.

• Angiotensin II (A1042): Technical Guidance for Vascular Mode

  2026-05-22

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) is an established peptide reagent for modeling hypertension mechanisms, vascular smooth muscle cell hypertrophy, and cardiovascular remodeling in research workflows. It is not intended for diagnostic or therapeutic applications; researchers should follow strict protocol and QC guidance to ensure reproducibility.

• Eltanexor (KPT-8602): Mechanisms and Evidence in Cancer Rese

  2026-05-22

  Eltanexor (KPT-8602) is a clinically advanced, orally bioavailable XPO1 inhibitor with proven efficacy in preclinical cancer models. It disrupts nuclear export, resulting in nuclear retention of tumor suppressors and reduced Wnt/β-catenin signaling. Eltanexor demonstrates potent cytotoxicity in hematological and solid tumor models, with improved tolerability over first-generation agents.

• Angiotensin II: Advanced Workflows for AAA and Vascular Mode

  2026-05-21

  Harness the full potential of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) for precision modeling of abdominal aortic aneurysm and vascular remodeling. This guide translates the latest senescence biomarker research and proven experimental optimizations into practical, reproducible workflows for cardiovascular laboratories.

• Toremifene Citrate: Advanced Strategies for Receptor Pathway

  2026-05-21

  Explore how Toremifene Citrate, a leading oral selective estrogen receptor modulator, enables advanced estrogen receptor signaling pathway investigations and breast cancer research. This in-depth analysis reveals nuanced methodological insights and critical protocol parameters for optimizing experimental outcomes.

• Viperin Disrupts Coronavirus Replication via nsp8 Targeting

  2026-05-20

  Zhou et al. (2026) uncover a conserved antiviral mechanism whereby viperin inhibits coronaviruses by directly binding non-structural protein 8 (nsp8), disrupting replication-transcription complex (RTC) assembly and impeding RNA-dependent RNA polymerase (RdRp) activity. These findings highlight new opportunities for broad-spectrum antiviral drug development targeting coronavirus RTC assembly.

• Oleanolic Acid: iNOS Induction & Dual-Loaded Liposome Protoc

  2026-05-20

  Oleanolic acid’s unique iNOS induction makes it a go-to antiviral research compound for dual-loaded liposome applications. This article translates recent encapsulation breakthroughs and workflow advances into actionable guidance, empowering reproducible immune modulation assays with APExBIO’s high-purity standard.

• Maternal Deltamethrin Exposure Drives p53-Mediated Ferroptos

  2026-05-19

  This study reveals that maternal exposure to deltamethrin during pregnancy and lactation impairs hippocampal learning and memory in male offspring via p53-mediated ferroptosis. The research identifies mechanistic links between p53 activation, iron metabolism, and neuronal loss, providing a model for investigating neurodevelopmental toxicity.

• Deracoxib in Translational Research: Mechanism, Models, and

  2026-05-19

  This article explores the advanced mechanistic underpinnings and translational opportunities of Deracoxib, a selective COX-2 inhibitor. Drawing on recent in vitro and in vivo insights, it guides researchers through optimized experimental design, contextualizes Deracoxib in the contemporary research landscape, and delivers actionable recommendations for maximizing impact in inflammation and cancer biology studies. A clear differentiation is made between standard product information and the deeper strategic perspective offered here.

• L-NMMA Acetate (SKU B6444): Reliable NOS Pathway Modulation

  2026-05-18

  This article examines L-NMMA acetate (SKU B6444) as a benchmark inhibitor for nitric oxide synthase (NOS) pathway studies. Through real-world laboratory scenarios, we demonstrate how this reagent, supplied by APExBIO, empowers researchers to improve data reliability, optimize protocols, and enhance interpretability in cell viability and differentiation assays.

• T-5224 in Neuroinflammation: Beyond Arthritis to AP-1 Target

  2026-05-18

  Explore T-5224, a selective C-Fos/AP-1 inhibitor, as a precision tool for dissecting neuroinflammatory mechanisms and advancing translational research. This article reveals novel AP-1-mediated signaling insights distinct from standard arthritis and inflammation workflows.

• Fosinopril Sodium in Translational CVD: Mechanisms & Strateg

  2026-05-17

  This thought-leadership article explores Fosinopril sodium’s unique mechanistic profile and workflow advantages as an ACE inhibitor for cardiovascular and renal translational research. Combining biochemical precision with strategic protocol recommendations, it critically situates Fosinopril sodium within the evolving therapeutic and experimental landscape—backed by clinical evidence, application-driven guidance, and a forward-looking perspective on next-generation hypertension models.

• Balanced Human Intestinal Organoid Systems via GSK-3 Inhibit

  2026-05-16

  This study establishes a tunable human intestinal organoid model that achieves a controlled balance between stem cell self-renewal and differentiation. By leveraging small molecule modulators, including GSK-3 inhibitors, the authors demonstrate increased cellular diversity and proliferative capacity under a single culture condition, advancing the scalability and utility of organoid-based research.

• Senescence Genes as Diagnostic Biomarkers in Abdominal Aorti

  2026-05-15

  This study identifies cellular senescence-associated genes, notably ETS1 and ITPR3, as robust diagnostic biomarkers for abdominal aortic aneurysm (AAA). Through integrative transcriptomic analysis and machine learning, the work provides a framework for noninvasive, molecular-based AAA detection and highlights senescent endothelial cells as key contributors to disease progression.

• Enhancing Protein Stability in DFCP1-ATGL Lipid Droplet Rese

  2026-05-15

  This thought-leadership article addresses the central challenge of maintaining protein stability during the investigation of lipid droplet metabolism, with a strategic focus on DFCP1-ATGL regulatory mechanisms. It blends mechanistic insights from the latest research with actionable recommendations for translational scientists, highlighting the pivotal role of APExBIO’s Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) in preserving labile protein complexes and ensuring reproducibility in advanced lipid biology workflows.

449 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page